RA

Ronak Agrawal

Active Director Director DIN 10612219
DIN 10612219 First appointment May 2024 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2024
Shareholding value Locked Premium profile

About Ronak Agrawal

Data last updated:

Ronak Agrawal has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Aries Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10612219
Primary Designation Director
First Appointment 02 May 2024
Oldest Company Age 21 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Aries Drugs Private Limited U24232UR2005PTC007478
Director02 May 20242005Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aries Drugs Private Limited
Premium access

Shareholding and investment profile for Ronak Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ronak Agrawal

Ronak Agrawal has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Aries Drugs Private Limited. Engaged in General Business. Contributes to corporate operations.

Ronak Agrawal is associated with 1 company as Director.

Ronak Agrawal has expertise in General Business.

Ronak Agrawal has 2 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available